CRSP8 promotes thyroid cancer progression by antagonizing IKKα-induced cell differentiation

CRSP8 plays an important role in recruiting mediators to genes through direct interaction with various DNA-bound transactivators. In this study, we uncovered the unique function of CRSP8 in suppressing thyroid cancer differentiation and promoting thyroid cancer progression via targeting IKK alpha signaling. CRSP8 was highly expressed in human thyroid cancer cells and tissues, especially in anaplastic thyroid cancer (ATC). Knockdown of CRSP8 suppressed cell growth, migration, invasion, stemness, and induced apoptosis and differentiation in ATC cells, while its overexpression displayed opposite effects in differentiated thyroid cancer (DTC) cells. Mechanistically, CRSP8 downregulated IKK alpha expression by binding to the IKK alpha promoter region (-257 to -143) to negatively regulate its transcription. Knockdown or overexpression of IKK alpha significantly reversed the expression changes of the differentiation and EMT-related markers and cell growth changes mediated by CRSP8 knockdown or overexpression in ATC or DTC cells. The in vivo study also validated that CRSP8 knockdown inhibited the growth of thyroid cancer by upregulating IKK alpha signaling in a mouse model of human ATC. Furthermore, we found that CRSP8 regulated the sensitivity of thyroid cancer cells to chemotherapeutics, including cisplatin and epirubicin. Collectively, our results demonstrated that CRSP8 functioned as a modulator of IKK alpha signaling and a suppressor of thyroid cancer differentiation, suggesting a potential therapeutic strategy for ATC by targeting CRSP8/IKK alpha pathway.

Automated summary

CRSP8 acts as a modulator of IKK alpha signaling and a suppressor of thyroid cancer differentiation, demonstrating potential therapeutic strategy for ATC. Knockdown of CRSP8 inhibits cell growth and invasion while inducing apoptosis and differentiation in thyroid cancer cells. The CRSP8/IKK alpha pathway may be a promising target for ATC treatment.